Biological valvular prothesis

• US 5,500,014 A
• Filed: 05/09/1994
• Issued: 03/19/1996
• Est. Priority Date: 05/31/1989
• Status: Expired due to Term

• Current Assignee: 3F Therapeutics Incorporated (Medtronic Plc)
• Original Assignee: Baxter International Inc.
• Inventors: Myers, Keith, Nashef, Aws, Quijano, R. C.
• Primary Examiner(s): ISABELLA, DAVID J
• Application Number:
  US08/240,286
• Time in Patent Office: 680 Days
• Field of Search: 623/1, 623/2, 623/11, 623/12, 623/66
• US Class Current: 623/1.24
• CPC Class Codes: A61B 17/12 for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord specially adapted for vas deferens or fallopian tubes A61F6/20; materials for ligaturing blood vessels A61L17/00
• CPC Class Codes: A61F 2/062 Apparatus for the production of blood vessels made from natural tissue or with layers of living cells prostheses made from natural tissue or living cells A61L27/507
• CPC Class Codes: A61F 2/07 Stent-grafts
• CPC Class Codes: A61F 2/2418 Scaffolds therefor, e.g. support stents
• CPC Class Codes: A61F 2/2475 Venous valves

Abstract

A biological valvular prosthesis defined by a chemically fixed biological derived conduit having at least one integrally formed tissue valve. The chemical fixation of the valve ensures that the leaflets remain open under normal forward blood flow conditions, but close under minimal backflow pressure. The biological valvular prostheses are useful in the replacement of venous valves and other biological valves. The biological valvular prosthesis may also be in the form of a tubular conduit bearing one tissue valve. This valvular conduit prosthesis is useful for the reconstruction of the pulmonary artery to correct various types of congenital defects.

Claims

1. A biological valvular prosthesis comprising:

a chemically fixed conduit derived from a harvested vein segment bearing at least one integrally formed venous valve, said venous valve having at least one valve leaflet, wherein said venous valve is chemically fixed while retaining said valve leaflet in a substantially open position; and

a restriction means positioned about said conduit at either side of said venous for restricting said venous valve from expanding outwardly, wherein said restriction means includes first and second rings positioned at opposite sides of said venous valve, with said rings being connected by one or more struts.

2. The biological valvular prosthesis of claim 1 wherein said at least one venous valve is chemically fixed while being retained in at least about seventy percent of its open position.

3. The biological valvular prosthesis of claim 1 wherein said at least one venous valve is chemically fixed to remain open at forward blood flow rates of greater than at least about one hundred milliliters/minute.

4. The biological valvular prosthesis of claim 2 wherein said at least one venous valve is chemically fixed to remain open at forward blood flow rates of greater than at least about one hundred milliliters/minute.

5. The biological valvular prosthesis of claim 3 wherein said at least one venous valve is chemically fixed to closed under back flow pressures of at least 0.1 mm Hg.

6. A biological valvular prosthesis comprising:

a chemically fixed conduit derived from a harvested vein segment bearing at least one integrally formed venous valve, said venous valve having at least one valve leaflet, wherein said venous valve is chemically fixed while retaining said valve leaflet in a substantially closed position; and

a restriction means positioned about said conduit at either side of said venous valve for restricting said venous valve from expanding outwardly, wherein said restriction means includes first and second rings positioned at opposite sides of said venous valve, with said rings being connected by one or more struts.

7. The biological valvular prosthesis of claim 6 wherein said at least one venous valve is chemically fixed to remain open at forward blood flow rates of greater than at least about one hundred milliliters/minute.

8. The biological valvular prosthesis of claim 7 wherein said at least one venous valve is chemically fixed to remain open at forward blood flow rates of greater than at least about one hundred milliliters/minute.

9. The biological valvular prosthesis of claim 8 wherein said at least one venous valve is chemically fixed to closed under back flow pressures of at least 0.1 mm Hg.

10. A biological valvular prosthesis comprising:

a chemically fixed conduit derived from a harvested vein segment bearing at least one venous valve, wherein said venous valve is chemically fixed while being retained in the open position, said conduit including means positioned about said conduit for restricting said venous valve from expanding outwardly and protecting said venous valve from compression, wherein said means for restricting includes first and second rings positioned at opposite sides of said venous valve, with said rings being connected by one or more struts.

11. The biological valvular prosthesis of claim 10 wherein said at least one venous valve is chemically fixed while being retained in at least about seventy percent of its open position.

12. The biological valvular prosthesis of claim 10 wherein said at least one venous valve is chemically fixed to remain open at forward blood flow rates of greater than at least about one hundred milliliters/minute.

13. The biological valvular prosthesis of claim 11 wherein said at least one venous valve is chemically fixed to remain open at forward blood flow rates of greater than at least about one hundred milliliters/minute.

14. The biological valvular prosthesis of claim 12 wherein said at least one venous valve is chemically fixed to closed under back flow pressures of at least 0.1 mm Hg.